Girao Tiago
Insider CIK 1618670 · CYTX VP & Chief Financial Officer · IMVT Chief Financial Officer · LABP Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| IMVT Immunovant, Inc. | S Sale | 2026-10-28 | 2026-10-30 | 6,606 | $28.50 | $188.3K | 234,192 | SEC↗ |
| IMVT Immunovant, Inc. | S Sale | 2026-07-23 | 2026-07-24 | 6,798 | $38.69 | $263.0K | 240,798 | SEC↗ |
| IMVT Immunovant, Inc. | M Exercise deriv | 2026-06-26 | 2026-06-26 | 10,000 | — | $0 | 283,505 | SEC↗ |
| IMVT Immunovant, Inc. | M Exercise | 2026-06-26 | 2026-06-26 | 10,000 | $15.90 | $159.0K | 257,596 | SEC↗ |
| IMVT Immunovant, Inc. | S Sale | 2026-06-26 | 2026-06-26 | 10,000 | $38.46 | $384.6K | 247,596 | SEC↗ |
| IMVT Immunovant, Inc. | S Sale | 2026-04-23 | 2026-04-24 | 25,760 | $29.62 | $763.0K | 247,596 | SEC↗ |
| IMVT Immunovant, Inc. | A Award deriv | 2026-04-07 | 2026-04-09 | 94,002 | — | $0 | 94,002 | SEC↗ |
| IMVT Immunovant, Inc. | A Award | 2026-04-07 | 2026-04-09 | 64,968 | — | $0 | 273,356 | SEC↗ |
| IMVT Immunovant, Inc. | A Award deriv | 2025-05-01 | 2025-05-05 | 293,505 | — | $0 | 293,505 | SEC↗ |
| IMVT Immunovant, Inc. | A Award | 2025-05-01 | 2025-05-05 | 208,388 | — | $0 | 208,388 | SEC↗ |
| LABP Landos Biopharma, Inc. | D To issuer deriv | 2024-05-23 | 2024-05-23 | 1,800 | — | $0 | 0 | SEC↗ |
| LABP Landos Biopharma, Inc. | D To issuer deriv | 2024-05-23 | 2024-05-23 | 1,800 | — | $0 | 0 | SEC↗ |
| LABP Landos Biopharma, Inc. | D To issuer deriv | 2024-05-23 | 2024-05-23 | 1,800 | — | $0 | 0 | SEC↗ |
| LABP Landos Biopharma, Inc. | A Award deriv | 2023-05-23 | 2023-05-24 | 18,000 | — | $0 | 18,000 | SEC↗ |
| LABP Landos Biopharma, Inc. | A Award deriv | 2022-06-07 | 2022-06-09 | 18,000 | — | $0 | 18,000 | SEC↗ |
| LABP Landos Biopharma, Inc. | A Award deriv | 2022-05-16 | 2022-05-18 | 18,000 | — | $0 | 18,000 | SEC↗ |
| LABP Landos Biopharma, Inc. | A Award deriv | 2021-04-08 | 2021-04-12 | 36,000 | — | $0 | 36,000 | SEC↗ |
| CTYX CYTORI THERAPEUTICS, INC. | X Exercise deriv | 2018-07-25 | 2018-07-27 | 1,050 | — | $0 | 1,050 | SEC↗ |
| CTYX CYTORI THERAPEUTICS, INC. | X Exercise deriv | 2018-07-25 | 2018-07-27 | 1 | — | $0 | 0 | SEC↗ |
| CTYX CYTORI THERAPEUTICS, INC. | X Exercise deriv | 2018-07-25 | 2018-07-27 | 1 | — | $0 | 1 | SEC↗ |
| CTYX CYTORI THERAPEUTICS, INC. | X Exercise deriv | 2017-11-28 | 2017-11-29 | 1 | — | $0 | 0 | SEC↗ |
| CTYX CYTORI THERAPEUTICS, INC. | X Exercise deriv | 2017-11-28 | 2017-11-29 | 1 | — | $0 | 1 | SEC↗ |
| CTYX CYTORI THERAPEUTICS, INC. | X Exercise deriv | 2017-11-28 | 2017-11-29 | 1,800 | — | $0 | 1,800 | SEC↗ |
| CTYX CYTORI THERAPEUTICS, INC. | A Award deriv | 2017-03-08 | 2017-03-10 | 42,000 | — | $0 | 42,000 | SEC↗ |
| CTYX CYTORI THERAPEUTICS, INC. | A Award deriv | 2017-03-08 | 2017-03-17 | 31,100 | — | $0 | 31,100 | SEC↗ |
| CYTX CYTORI THERAPEUTICS, INC. | X Exercise deriv | 2016-06-15 | 2016-06-15 | 5,667 | — | $0 | 0 | SEC↗ |
| CYTX CYTORI THERAPEUTICS, INC. | X Exercise deriv | 2016-06-15 | 2016-06-15 | 2,833 | — | $0 | 2,833 | SEC↗ |
| CYTX CYTORI THERAPEUTICS, INC. | X Exercise | 2016-06-15 | 2016-06-15 | 5,667 | — | $0 | 14,084 | SEC↗ |
| CYTX CYTORI THERAPEUTICS, INC. | A Award | 2016-01-28 | 2016-02-01 | 35,250 | — | $0 | 123,250 | SEC↗ |
| CYTX CYTORI THERAPEUTICS, INC. | A Award | 2016-01-28 | 2016-02-05 | 35,250 | — | $0 | 126,250 | SEC↗ |
| CYTX CYTORI THERAPEUTICS, INC. | A Award deriv | 2016-01-04 | 2016-01-04 | 349,830 | — | $0 | 619,830 | SEC↗ |
| CYTX CYTORI THERAPEUTICS, INC. | P Buy | 2015-08-18 | 2015-08-19 | 25,000 | $0.39 | $9.8K | 88,000 | SEC↗ |
| CYTX CYTORI THERAPEUTICS, INC. | A Award deriv | 2015-01-30 | 2015-02-03 | 120,000 | — | $0 | 270,000 | SEC↗ |
| CYTX CYTORI THERAPEUTICS, INC. | P Buy | 2014-11-12 | 2014-11-12 | 44,111 | $0.39 | $17.2K | 60,000 | SEC↗ |
| CYTX CYTORI THERAPEUTICS, INC. | P Buy | 2014-11-11 | 2014-11-12 | 15,889 | $0.39 | $6.2K | 15,889 | SEC↗ |
| CYTX CYTORI THERAPEUTICS, INC. | A Award deriv | 2014-09-02 | 2014-09-04 | 150,000 | — | $0 | 150,000 | SEC↗ |